Familial Recurrence Rate of Autism Spectrum Disorder 20.2 Percent
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 17, 2024 -- The familial recurrence rate of autism spectrum disorder (ASD) is 20.2 percent, which has not changed significantly from previous estimates, according to a study published online July 16 in Pediatrics.
Sally Ozonoff, Ph.D., from the University of California Davis Health in Sacramento, and colleagues collated data across 18 sites of the Baby Siblings Research Consortium to update estimates of familial ASD recurrence. A total of 1,605 infants with an older sibling with autism were followed from early in life to age 3 years, at which point they were classified as ASD or non-ASD.
The researchers found that 20.2 percent of siblings developed ASD, which is not significantly different from the previously reported rate (18.7 percent). Significant predictors of familial recurrence included male infant sex and more than one older affected sibling. Recurrence rates were also influenced by proband sex, with the likelihood of developing ASD significantly higher for siblings of female probands than siblings of male probands. Associations were also seen for race and maternal education with recurrence in families.
"The current study reinforces the importance of developmental surveillance and screening for younger siblings of autistic children, particularly those who are male, have an affected female sibling, or have multiple affected siblings," the authors write.
Several authors disclosed ties to the pharmaceutical and publishing industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency
THURSDAY, June 12, 2025 -- Clinical use of artificial intelligence (AI)-generated draft radiograph reports is associated with improved radiologist documentation efficiency while...
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.